首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1319139

全球心血管假體設備市場 - 2023-2030 年

Global Cardiovascular Prosthetic Device Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球心血管假體設備市場規模達到153 億美元，預計到2030 年將達到289 億美元，2023-2030 年的年複合成長率為8.4%。

心血管假體設備可模仿人體心臟部件的功能。這些裝置被替換到人體中，以修復故障或修復受損的瓣膜或組織。心臟假體的設計目的是通過保持單向血流來複製原生瓣膜的功能，而且所使用的材料必須是抗凝血的，儘管它是有生命的。

心血管假體設備是可植入或外置的設備，用於替代或輔助心血管系統的各個部分，如心臟、動脈或靜脈。心臟修復裝置可提高大多數患者的生存率，並顯著提高生活品質。雅培實驗室、波士頓科學公司、美敦力公司等主要企業都在積極開拓這一市場。

市場動態

心力衰竭發病率上升推動市場成長

心力衰竭發病率的增加在促進市場成長方面發揮了重要作用。許多人患有心臟中風和心力衰竭，這提高了植入率。心力衰竭是影響許多人的主要問題。例如，據美國心力衰竭協會統計，每年新增心力衰竭病例96萬例。每年約有3770 萬人住院治療。因此，心衰患者發病率的增加正在擴大市場成長。

老年人口的增加推動了市場成長

老年人口發病率的增加推動了市場的成長。老齡化是影響心臟正常功能的主要因素之一。隨著年齡的成長，心臟功能會受到不利影響。衰老會導致心臟和血管發生變化。

例如，據美國心臟協會期刊估計，70 歲以上的人中有70% 會患上心血管疾病。據報導，在45 歲及以上的成年人中，有14.2% 的人患有冠心病、中風或同時患有這兩種疾病。因此，老年人口數量的增加將擴大市場成長。

植入治療的高成本將阻礙市場成長

植入治療的高成本會阻礙市場成長。由於手術的複雜性增加，與植入相關的手術治療費用也隨之增加。例如，美國心臟起搏器手術的平均費用在2,000 美元至2,500 美元之間。

COVID-19 影響分析

COVID-19 大流行對心血管修復裝置產生了重大影響，給許多國家帶來了前所未有的挑戰。外科手術的延遲和推遲，以及病人對醫院的恐懼，都對心血管修復裝置的使用產生了影響。這導致在COVID-19 大流行期間，心血管修復裝置的成長大幅下降。

俄烏戰爭影響分析

據估計，俄烏衝突對心血管假體設備的影響不大，因為該地區的主要市場參與者較少。不過，原料進出口的影響預計在預測期內對心血管修復裝置的成長影響不大。

Market Overview

Global Cardiovascular Prosthetic Device Market reached US$ 15.3 billion in 2022 and is expected to reach US$ 28.9 billion by 2030 growing with a CAGR of 8.4% during the forecast period 2023-2030.

A cardiovascular prosthetic device mimics the functions of the parts of the human heart. These devices are replaced in the human body in order to repair the malfunction or to repair the damaged valves or tissues. The cardiac prosthesis is designed to replicate the function of native valves by maintaining unidirectional blood flow, and the material that is used should be anticoagulant although life.

Cardiovascular prosthetic devices are implantable or external devices that replace or assist parts of the cardiovascular system, such as the heart, arteries, or veins. Prosthetic cardiac devices improve survival and significantly increase the quality of life in most patients. Significant key players like Abbott Laboratories, Boston Scientific, Medtronic, among others are actively operating in the market.

Market Dynamics

An Increase in the Incidence of Heart Failure is Boosting the Market Growth

An increase in the incidence of heart failure is playing a major role in boosting market growth. A large number of people are suffering from heart strokes and heart failure,which is increasing the rate of implantations. Heart failure is a major problem affecting many people. For instance, according tothe Heart Failure Society of America, 960,000 new heart failure cases annually. About 37.7 million people are hospitalized each year. Thus, the increase in the incidence of heart failure patients is expanding the market growth.

An Increase in the Geriatric Population is Fueling the Market Growth

The increase in the incidence of the geriatric populationis fueling the growth of the market. Aging is one of the major factors which shows the influence on the functioning of the heart properly. Heart function gets adversely affected as age increases. Aging can cause changes in the heart and blood vessels.

For instance, according to AHA Journals, it is estimated that 70% of people over 70 years old will develop CVD. 14.2% of adults aged 45 years and older reported having coronary heart disease (CHD), a stroke, or both. Thus increase in the number of aged population will expand the market growth.

High Cost of the Implantation Treatments Will Hamper the Market Growth

The high cost of the implantation treatments can hamper market growth. There is an increased cost for the treatments of surgeries related to implantation due to the increase in the complexity of the surgery. For instance, the average cost of pacemaker surgery in the US ranges between US$2,000- US$ 2,500.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on cardiovascular prosthetic devices, posing unprecedented challenges to many countries. The delayed surgical procedures and postponements of the surgeries, and the fear of patients approaching hospitals have shown the impact on the usage of cardiovascular prosthetic devices. This resulted in a significant decline in the cardiovascular prosthetic device growth during the COVID-19 pandemic.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the cardiovascular prosthetic device, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the cardiovascular prosthetic device growth over the forecast period.

Segment Analysis

The cardiovascular prosthetic device is segmented based on product type and end user.

The Implanted Heart Valve Segment Accounts for Approximately 23.8% of the Cardiovascular Prosthetic Device Share

An implanted heart valve is a one-way valve implanted into a person's heart to replace a heart valve that is not functioning properly. Due to the increase in the number of congenital heart valve diseases, implanted heart valve segment holds the highest market share.

According to texasheart.org, in the United States, surgeons perform about 106,000 heart valve operations each year. Each year approximately 40,000 babies are born in the United States with a congenital heart defect. Thus the above factors are influencing the segment to lead the market.

Geographical Analysis

Asia Pacific region accounted for Approximately 21.3% of the Market Share Owing to Technological Advancements

The rise in technological advancements and innovation of new devices is boosting the market share in Asia-Pacific region. A number of clinical trials and approvals have been taking place in this region in order to introduce a number of treatment methods and reduce mortality inthe region.

For instance, on 19 April 2022, Translumina announced the launch of the Vivo Isar dual-drug polymer-free coated stent in various international markets, including Europe and Asia-Pacific regions. Thus, the increase in technological advancements and new innovations is raising the growth of the market.

Competitive Landscape

The major global players in the cardiovascular prosthetic device market include: Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co. Ltd, Medtronic Inc, Biotronik, Meril Life Sciences Pvt. Ltd, Pacetronix, MicroPort Scientific Corporation, Artivion, Inc, and JC Medical, Inc among others.

Why Purchase the Report?

To visualize the cardiovascular prosthetic device segmentation based on product type, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of cardiovascular prosthetic device market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The cardiovascular prosthetic device report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by End-User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. An increase in the incidence of cardiovascular diseases
  - 4.1.1.2. Increase in the number of obese patients
- 4.1.2. Restraints
  - 4.1.2.1. Complications associated with the devices
- 4.1.3. Opportunity
  - 4.1.3.1. Increased number of treatments
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. ByProduct Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Pacemakers
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Implanted Heart Valves
7.4. Stents
7.5. Others

8. ByEnd User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics/Cardiac Centers
8.4. Ambulatory Surgical Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan

Australia

9.5.5.4. Rest of Asia-Pacific

9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Artivion, Inc
11.3. Biotronik
11.4. MicroPort Scientific Corporation
11.5. JC Medical, Inc
11.6. Boston Scientific
11.7. Pacetronix
11.8. Meril Life Sciences Pvt. Ltd
11.9. Medtronic
11.10. Lepu Medical Technology Co. Ltd

LIST NOT EXHAUSTIVE

12. Appendix

12.1. About Us and Services
12.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ